Matches in DBpedia 2014 for { ?s ?p <http://dbpedia.org/resource/Category:Monoclonal_antibodies> . }
- Abciximab subject Category:Monoclonal_antibodies.
- Abzyme subject Category:Monoclonal_antibodies.
- Actoxumab subject Category:Monoclonal_antibodies.
- Adalimumab subject Category:Monoclonal_antibodies.
- Aducanumab subject Category:Monoclonal_antibodies.
- Alacizumab_pegol subject Category:Monoclonal_antibodies.
- Alirocumab subject Category:Monoclonal_antibodies.
- Amatuximab subject Category:Monoclonal_antibodies.
- Anifrolumab subject Category:Monoclonal_antibodies.
- Anti-CD19_immunotoxin subject Category:Monoclonal_antibodies.
- Anti-CD3_monoclonal_antibody subject Category:Monoclonal_antibodies.
- Apolizumab subject Category:Monoclonal_antibodies.
- Aselizumab subject Category:Monoclonal_antibodies.
- Atinumab subject Category:Monoclonal_antibodies.
- Atorolimumab subject Category:Monoclonal_antibodies.
- Belimumab subject Category:Monoclonal_antibodies.
- Benralizumab subject Category:Monoclonal_antibodies.
- Bezlotoxumab subject Category:Monoclonal_antibodies.
- Bi-specific_T-cell_engager subject Category:Monoclonal_antibodies.
- Bimagrumab subject Category:Monoclonal_antibodies.
- Bispecific_monoclonal_antibody subject Category:Monoclonal_antibodies.
- Bivatuzumab subject Category:Monoclonal_antibodies.
- Brentuximab_vedotin subject Category:Monoclonal_antibodies.
- CBR96-doxorubicin_immunoconjugate subject Category:Monoclonal_antibodies.
- Cambridge_Antibody_Technology subject Category:Monoclonal_antibodies.
- Cantuzumab subject Category:Monoclonal_antibodies.
- Cantuzumab_ravtansine subject Category:Monoclonal_antibodies.
- Caplacizumab subject Category:Monoclonal_antibodies.
- Cedelizumab subject Category:Monoclonal_antibodies.
- Chemically_linked_Fab subject Category:Monoclonal_antibodies.
- Citatuzumab_bogatox subject Category:Monoclonal_antibodies.
- Cixutumumab subject Category:Monoclonal_antibodies.
- Clenoliximab subject Category:Monoclonal_antibodies.
- Crenezumab subject Category:Monoclonal_antibodies.
- Daclizumab subject Category:Monoclonal_antibodies.
- Daratumumab subject Category:Monoclonal_antibodies.
- Demcizumab subject Category:Monoclonal_antibodies.
- Denosumab subject Category:Monoclonal_antibodies.
- Drozitumab subject Category:Monoclonal_antibodies.
- Dupilumab subject Category:Monoclonal_antibodies.
- Dusigitumab subject Category:Monoclonal_antibodies.
- Ecromeximab subject Category:Monoclonal_antibodies.
- Edobacomab subject Category:Monoclonal_antibodies.
- Eldelumab subject Category:Monoclonal_antibodies.
- Elsilimomab subject Category:Monoclonal_antibodies.
- Enavatuzumab subject Category:Monoclonal_antibodies.
- Enokizumab subject Category:Monoclonal_antibodies.
- Enoticumab subject Category:Monoclonal_antibodies.
- Ensituximab subject Category:Monoclonal_antibodies.
- Erlizumab subject Category:Monoclonal_antibodies.
- Etrolizumab subject Category:Monoclonal_antibodies.
- Exbivirumab subject Category:Monoclonal_antibodies.
- Faralimomab subject Category:Monoclonal_antibodies.
- Farletuzumab subject Category:Monoclonal_antibodies.
- Fasinumab subject Category:Monoclonal_antibodies.
- Felvizumab subject Category:Monoclonal_antibodies.
- Ficlatuzumab subject Category:Monoclonal_antibodies.
- Flanvotumab subject Category:Monoclonal_antibodies.
- Fontolizumab subject Category:Monoclonal_antibodies.
- Foralumab subject Category:Monoclonal_antibodies.
- Foravirumab subject Category:Monoclonal_antibodies.
- Fresolimumab subject Category:Monoclonal_antibodies.
- Galiximab subject Category:Monoclonal_antibodies.
- Gantenerumab subject Category:Monoclonal_antibodies.
- Gevokizumab subject Category:Monoclonal_antibodies.
- Girentuximab subject Category:Monoclonal_antibodies.
- Gomiliximab subject Category:Monoclonal_antibodies.
- Guselkumab subject Category:Monoclonal_antibodies.
- HuMax subject Category:Monoclonal_antibodies.
- Human_anti-mouse_antibody subject Category:Monoclonal_antibodies.
- Humanized_antibody subject Category:Monoclonal_antibodies.
- IMAB362 subject Category:Monoclonal_antibodies.
- Ibalizumab subject Category:Monoclonal_antibodies.
- Icrucumab subject Category:Monoclonal_antibodies.
- Inclacumab subject Category:Monoclonal_antibodies.
- Indatuximab_ravtansine subject Category:Monoclonal_antibodies.
- Infliximab subject Category:Monoclonal_antibodies.
- Inolimomab subject Category:Monoclonal_antibodies.
- Itolizumab subject Category:Monoclonal_antibodies.
- Keliximab subject Category:Monoclonal_antibodies.
- Lampalizumab subject Category:Monoclonal_antibodies.
- Lebrikizumab subject Category:Monoclonal_antibodies.
- Lemalesomab subject Category:Monoclonal_antibodies.
- Lerdelimumab subject Category:Monoclonal_antibodies.
- Libivirumab subject Category:Monoclonal_antibodies.
- Ligelizumab subject Category:Monoclonal_antibodies.
- List_of_therapeutic_monoclonal_antibodies subject Category:Monoclonal_antibodies.
- Lumiliximab subject Category:Monoclonal_antibodies.
- Maslimomab subject Category:Monoclonal_antibodies.
- Mavrilimumab subject Category:Monoclonal_antibodies.
- Metelimumab subject Category:Monoclonal_antibodies.
- Milatuzumab subject Category:Monoclonal_antibodies.
- Mogamulizumab subject Category:Monoclonal_antibodies.
- Monoclonal_antibody subject Category:Monoclonal_antibodies.
- Morolimumab subject Category:Monoclonal_antibodies.
- Moxetumomab_pasudotox subject Category:Monoclonal_antibodies.
- Namilumab subject Category:Monoclonal_antibodies.
- Narnatumab subject Category:Monoclonal_antibodies.
- Natalizumab subject Category:Monoclonal_antibodies.
- Nebacumab subject Category:Monoclonal_antibodies.